These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 28464925)
21. A novel in silico platform for a fully automatic personalized brain tumor growth. Hajishamsaei M; Pishevar A; Bavi O; Soltani M Magn Reson Imaging; 2020 May; 68():121-126. PubMed ID: 31911200 [TBL] [Abstract][Full Text] [Related]
22. Patient-specific parameter estimates of glioblastoma multiforme growth dynamics from a model with explicit birth and death rates. Han LF; Eikenberry S; He CH; Johnson L; Preul MC; Kostelich EJ; Kuang Y Math Biosci Eng; 2019 Jun; 16(5):5307-5323. PubMed ID: 31499714 [TBL] [Abstract][Full Text] [Related]
24. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging. Ahn SS; Shin NY; Chang JH; Kim SH; Kim EH; Kim DW; Lee SK J Neurosurg; 2014 Aug; 121(2):367-73. PubMed ID: 24949678 [TBL] [Abstract][Full Text] [Related]
25. Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease. Radaelli E; Ceruti R; Patton V; Russo M; Degrassi A; Croci V; Caprera F; Stortini G; Scanziani E; Pesenti E; Alzani R Histol Histopathol; 2009 Jul; 24(7):879-91. PubMed ID: 19475534 [TBL] [Abstract][Full Text] [Related]
26. Association of Radiomics and Metabolic Tumor Volumes in Radiation Treatment of Glioblastoma Multiforme. Lopez CJ; Nagornaya N; Parra NA; Kwon D; Ishkanian F; Markoe AM; Maudsley A; Stoyanova R Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):586-595. PubMed ID: 28011044 [TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance diffusion metrics indexing high focal cellularity and sharp transition at the tumour boundary predict poor outcome in glioblastoma multiforme. Jamjoom AA; Rodriguez D; Rajeb AT; Manita MA; Shah KA; Auer DP Clin Radiol; 2015 Dec; 70(12):1400-7. PubMed ID: 26403545 [TBL] [Abstract][Full Text] [Related]
28. Simulating chemotherapeutic schemes in the individualized treatment context: the paradigm of glioblastoma multiforme treated by temozolomide in vivo. Stamatakos GS; Antipas VP; Uzunoglu NK Comput Biol Med; 2006 Nov; 36(11):1216-34. PubMed ID: 16207487 [TBL] [Abstract][Full Text] [Related]
30. High order diffusion tensor imaging in human glioblastoma. Ellingson BM; Cloughesy TF; Lai A; Nghiemphu PL; Liau LM; Pope WB Acad Radiol; 2011 Aug; 18(8):947-54. PubMed ID: 21536466 [TBL] [Abstract][Full Text] [Related]
31. From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment response. Gallaher JA; Massey SC; Hawkins-Daarud A; Noticewala SS; Rockne RC; Johnston SK; Gonzalez-Cuyar L; Juliano J; Gil O; Swanson KR; Canoll P; Anderson ARA PLoS Comput Biol; 2020 Feb; 16(2):e1007672. PubMed ID: 32101537 [TBL] [Abstract][Full Text] [Related]
32. Simulating glioblastoma growth consisting both visible and invisible parts of the tumor using a diffusion-reaction model followed by resection and radiotherapy. Moshtaghi-Kashanian N; Niroomand-Oscuii H; Meghdadi N Acta Neurol Belg; 2020 Jun; 120(3):629-637. PubMed ID: 29869778 [TBL] [Abstract][Full Text] [Related]
33. Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models. Kickingereder P; Burth S; Wick A; Götz M; Eidel O; Schlemmer HP; Maier-Hein KH; Wick W; Bendszus M; Radbruch A; Bonekamp D Radiology; 2016 Sep; 280(3):880-9. PubMed ID: 27326665 [TBL] [Abstract][Full Text] [Related]
34. Tracking glioblastoma progression after initial resection with minimal reaction-diffusion models. Harris DC; Mignucci-Jiménez G; Xu Y; Eikenberry SE; Quarles CC; Preul MC; Kuang Y; Kostelich EJ Math Biosci Eng; 2022 Mar; 19(6):5446-5481. PubMed ID: 35603364 [TBL] [Abstract][Full Text] [Related]
35. High-grade glioma diffusive modeling using statistical tissue information and diffusion tensors extracted from atlases. Roniotis A; Manikis GC; Sakkalis V; Zervakis ME; Karatzanis I; Marias K IEEE Trans Inf Technol Biomed; 2012 Mar; 16(2):255-63. PubMed ID: 21990337 [TBL] [Abstract][Full Text] [Related]
36. Diffusion tensor imaging-derived biomarkers performance in glioblastoma tumor regions: exploratory data analysis using zombie plots and diagnostic tests. Roldán-Valadez E; Anaya-Sánchez S; Rivera-Sotelo N; Moreno-Jiménez S Gac Med Mex; 2022; 158(1):55-62. PubMed ID: 35404923 [TBL] [Abstract][Full Text] [Related]
37. Computational modeling of tumor invasion from limited and diverse data in Glioblastoma. Jonnalagedda P; Weinberg B; Min TL; Bhanu S; Bhanu B Comput Med Imaging Graph; 2024 Oct; 117():102436. PubMed ID: 39342741 [TBL] [Abstract][Full Text] [Related]
38. A Monte Carlo based formalism to identify potential locations at high risk of tumor recurrence with a numerical model for glioblastoma multiforme. Trepanier PY; Fortin I; Lambert C; Lacroix F Med Phys; 2012 Nov; 39(11):6682-91. PubMed ID: 23127062 [TBL] [Abstract][Full Text] [Related]
40. Predicting Glioblastoma Recurrence by Early Changes in the Apparent Diffusion Coefficient Value and Signal Intensity on FLAIR Images. Chang PD; Chow DS; Yang PH; Filippi CG; Lignelli A AJR Am J Roentgenol; 2017 Jan; 208(1):57-65. PubMed ID: 27726412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]